Description
Safinamide is a drug indicated for the treatment of Parkinson's disease with multiple methods of action. Potential additional uses might be restless leg syndrome and epilepsy. Safinamide is a reversible and selective monoamine oxidase B inhibitor, reducing the degradation of dopamine, and a glutamate release inhibitor. It also inhibits dopamine reuptake. Safinamide also blocks sodium and calcium channels